In Brief
Refine Search
Biotechnology
Germany’s Evotec says it has taken notice of the statement made by Halozyme Therapeutics on November 22, stating that it has withdrawn its non-binding proposal to acquire Evotec for 11.00 euros per share in cash. 23 November 2024
Biotechnology
Colorado, USA-based OncoVerity announced the closing of a series A extension led by existing investors, argenX and RefinedScience. The value was not disclosed, but this extension follows a $30 million Series A fundraiser in March 2023. 22 November 2024
Biotechnology
Sweden-based BioArctic saw its fall 7.5% to 139.90 kronor on Friday, after its announced that its partner, Japan’s Eisa, has updated its revenue outlook for the Alzheimer’s treatment Leqembi (lecanemab) for the 2024 fiscal year (FY), which runs from April 2024 through March 2025. 11 November 2024
Biotechnology
Danish biotech Gubra announces that Germany’s Boehringer Ingelheim has decided to discontinue the development of the long-acting neuropeptide Y receptor type 2 (NPY2R) agonist BI 1820237 in obesity. 4 November 2024
Biotechnology
Japanese drugmaker Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (US brand name Leqembi) subcutaneous autoinjector for weekly maintenance dosing after it was granted Fast Track designation by the FDA. 1 November 2024
Pharmaceutical
GSK has announced its largest US manufacturing investment to date, dedicated to producing medicines and vaccines. 25 October 2024
Pharmaceutical
Following a re-examination, the European Medicines Agency’s human health committee, CHMP confirmed its initial recommendation to refuse the granting of a conditional marketing authorization for Masitinib AB Science’s masitinib. 18 October 2024
Pharmaceutical
University Medical Center Groningen (UMCG) and SHINE Europe have secured a 10.5 million euro ($11 million) grant to advance European production of terbium isotopes for cancer treatments. 17 October 2024
Pharmaceutical
Danish dermatology focused LEO Pharma has announced the launch of Anzupgo (delgocitinib) cream in Germany for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate. 15 October 2024
Pharmaceutical
French pharma major Sanofi revealed it has entered into negotiations with private equity firm Clayton Dubilier & Rice (CD&R) for the potential sale of a 50% controlling stake in Opella, its consumer healthcare business. 14 October 2024
Pharmaceutical
The UK’s new 2024 voluntary scheme for branded medicines pricing, access, and growth (VPAG) came into force at the beginning of January this year. 4 October 2024
Biotechnology
Sirnaomics, a firm specializing in RNAi therapeutics, has entered into a subscription agreement with biotech specialist Poon Hung Fai. 4 October 2024
Biotechnology
GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the US Department of Health and Human Services (HHS). 4 October 2024
Biotechnology
Oxford, UK-based Enara Bio today announces the closing of a $32.5 million Series B financing supported by a strong syndicate of new and existing biotech investors. 3 October 2024
Pharmaceutical
French drugmaker Mitem Pharmavhas the worldwide acquisition of Desferal (deferoxamine), a major MITM in hematology, from Swiss giant Novartis. 25 September 2024
article
The European Medicines Agency’s (EMA) Committee for Human Medicinal Products (CHMP) has elected Bruno Sepodes as its new chair. 19 September 2024
Pharmaceutical
The Austrian Academy of Sciences (OeAW) is further expanding its focus on life sciences by opening an institute for biomedical artificial intelligence (AI) based on a 150 million euros ($166.8 million) funding from the German non-profit Boehringer Ingelheim Foundation (BIS). 18 September 2024
Biotechnology
Zenas BioPharma announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. 13 September 2024
Biotechnology
US pharma major Eli Lilly and Egyptian firm EVA Pharma have entered into an agreement to expand access to Olumiant (baricitinib) to an estimated 20,000 people in 49 low- to middle-income countries in Africa by 2030. 6 September 2024
Biotechnology
German pharma and life sciences major Merck KGaA today revealed it plans to invests more than 300 million euros ($32.7 million) into a new Bioprocessing Production Center in Daejeon, South Korea. 20 March 2024
Biotechnology
Germany’s BioNTech has announced the appointment of Annemarie Hanekamp as the company’s new chief commercial officer, succeeding Sean Marett. 20 March 2024
Biotechnology
German BioNTech stock fell nearly 9% to 85.72 euros in early trading today, as the company – which came into the limelight with the super successful COVID-19 vaccine Comirnaty partnered with Pfizer – as it posted financial results that disappointed. 20 March 2024
Pharmaceutical
A statement from the Centers for Disease Control and Prevention (CDC) in the USA raises concerns about the spread of measles, a public health issue which has affected multiple countries in recent years. 20 March 2024
Pharmaceutical
Italfarmaco has announced that results from its pivotal Phase III EPIDYS trial with givinostat in ambulant boys aged six years and older with Duchenne muscular dystrophy (DMD) have been published in The Lancet Neurology. 20 March 2024
Biotechnology
Following the US Food and Drug Administration approval last Friday of its Lenmeldy (atidarsagene autotemcel), Orchard Therapeutics today announced launch plans for the gene therapy. 20 March 2024
Pharmaceutical
The US Food and Drug Administration (FDA) has approved Tryvio (aprocitentan) for the treatment of hypertension. 20 March 2024
Biotechnology
Capping a series of investments designed to increase its manufacturing footprint, Novo Nordisk has said it will spend around $550 million to up output in China. 20 March 2024
Pharmaceutical
The US Food and Drug Administration (FDA) has granted accelerated approved the supplemental new drug application (sNDA) for Iclusig (ponatinib). 20 March 2024
Pharmaceutical
Positive results from French eye drug company Nicox have been published in the American Journal of Ophthalmology. 20 March 2024
Biotechnology
Precision neuroscience company Engrail Therapeutics has announced the close of an oversubscribed $157 million Series B financing round. 20 March 2024
Generics
Members of the European Parliament’s health committee (ENVI) yesterday adopted a compromise position on the EU Pharmaceutical legislation review (comprising of a new Pharmaceutical Directive and Regulation). 20 March 2024
Biotechnology
Swiss contract development and manufacturing organization (CDMO) today announced the signing of an agreement to acquire the Genentech large-scale biologics manufacturing site in Vacaville, California (US) from Swiss pharma giant Roche for $1.2 billion. 20 March 2024
Pharmaceutical
Madrigal Pharmaceuticals saw its shares close down 6.2% at $265.68 yesterday, after it announced the pricing of its underwritten public offering of 750,000 shares of its common stock. 20 March 2024
Biotechnology
Germany’s Boehringer Ingelheim has announced that the US Food and Drug Administration has given a new approval to Spevigo (spesolimab-sbzo). 19 March 2024
Biotechnology
American biotech PTC Therapeutics has submitted to the US regulator for approval to market Upstaza (eladocagene exuparvovec). 19 March 2024
Pharmaceutical
Since the early 1980s, the Sultanate of Oman has been one of the first countries in the MENA region to establish “a state reserve stock” of essential medicines and medical supplies to deal with emergency situations, mitigate the effects of epidemics and disasters, and provide the necessary medical and emergency care at the proper time. 19 March 2024
Pharmaceutical
Even as India's 'vaccine diplomacy' initiative, supplying life-saving doses to low- and middle-income countries, embodies a larger cooperative mission for global health security, the humanitarian effort stands in stark contrast to the reality of India's own domestic vaccine market, dominated by multinational corporations (MNCs). 19 March 2024
Biotechnology
The US Food and Drug Administration approved Lenmeldy (atidarsagene autotemcel), the first FDA-approved gene therapy indicated for the treatment of children with pre-symptomatic late infantile, pre-symptomatic early juvenile or early symptomatic early juvenile metachromatic leukodystrophy (MLD). 19 March 2024
Pharmaceutical
Crinetics Pharmaceuticals, a biopharma focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors, was trading 14% higher by lunchtime Tuesday. 19 March 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze